Surge in COVID-19 cases: Booster shot to prevent infection may do more harm than good, says AIIMS doctor Kajal Rajput17 April 2023 9:30 AM IST"There is no research on how effective the booster dose will be if you are already infected. And if this new variant is infecting you by bypassing...
Revise Phase IV CT Protocol: CDSCO panel tells Zydus Lifesciences on Typhoid Vi Conjugate Vaccine with Yellow Fever Vaccine Dr. Divya Colin15 April 2023 5:15 PM ISTNew Delhi: In response to the drug major Zydus Life Sciences' proposal to conduct Phase IV clinical for Typhoid Vi Conjugate Vaccine I.P.(TCV) with...
University of Oxford Malaria vaccine gets regulatory clearance for use in Ghana Ruchika Sharma14 April 2023 12:07 PM ISTThe vaccine has been approved for use in children aged 5 to 36 months, the age group at highest risk of death from malaria.
Flu vaccine did not meet criteria for early success in late-stage trial: Moderna Ruchika Sharma12 April 2023 1:30 PM ISTModerna President Stephen Hoge in an interview said he expected to start generating revenue from the flu vaccine in 2024, although the amount would...
Serum Institute Covovax likely to be available at Rs 225 per dose on CoWIN portal Ruchika Sharma10 April 2023 2:00 PM ISTCovovax was granted emergency-use listing by the World Health Organization on December 17, 2021.
Merck, Moderna get PRIME scheme designation from EMA for personalized mRNA cancer vaccine, KEYTRUDA combo for adjuvant treatment of High-risk Melanoma Ruchika Sharma9 April 2023 2:30 PM ISTMelanoma, the most serious form of skin cancer, is characterized by the uncontrolled growth of pigment-producing cells.
Pfizer RSV vaccine 82 percent effective in severe infection in infants: Data Ruchika Sharma7 April 2023 12:30 PM ISTFDA approval could make Pfizer's shot the first maternal vaccine available to prevent the disease in infants.
COVID vaccine: SII seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults Ruchika Sharma4 April 2023 11:00 AM ISTCovovax is manufactured through technology transfer from US-based vaccine maker Novavax.
Four COVID vaccine doses superior to three in patients with autoimmune rheumatic disease Dr. Shravani Dali1 April 2023 5:30 AM ISTFour COVID vaccine doses superior to three in patients with autoimmune rheumatic disease suggests a new study published in Rheumatology.The...
Johnson and Johson to discontinue late-stage study of RSV vaccine Ruchika Sharma31 March 2023 4:00 PM ISTPfizer and GSK are running a tight race to tap into the RSV vaccine market, which is estimated to be more than $5 billion and could exceed $10 billion...
Covid-19 vaccination not tied to menstrual disturbance, study finds Dr. Kamal Kant Kohli28 March 2023 8:00 PM ISTUK: A recent study has found that the COVID-19 vaccine is not associated with abnormal menstrual cycle parameters. However, women with a history of...
Indian Immunologicals wins DCGI okay to manufacture Measles-Rubella vaccine Ruchika Sharma28 March 2023 2:15 PM ISTThis vaccine has been proven through extensive human clinical trials to be immunogenic and safe for people of 9 months to 49 years, it said.
